Palvella Therapeutics, Inc.
PVLA
$23.98
-$0.45-1.84%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.21M | 14.54M | 7.35M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 441.00K | 307.00K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 1.67M | 500.00K | -- | -- | |
| Total Current Assets | 16.32M | 15.34M | -- | -- | |
|
|
|||||
| Total Current Assets | 16.32M | 15.34M | -- | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 16.32M | 15.34M | -- | -- | |
|
|
|||||
| Total Accounts Payable | 3.13M | 1.45M | -- | -- | |
| Total Accrued Expenses | 4.22M | 2.72M | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 282.00K | 231.00K | -- | -- | |
| Total Other Current Liabilities | 282.00K | 231.00K | -- | -- | |
| Total Current Liabilities | 7.64M | 4.40M | -- | -- | |
|
|
|||||
| Total Current Liabilities | 7.64M | 4.40M | -- | -- | |
| Long-Term Debt | 24.07M | 19.83M | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 1.42M | 1.34M | -- | -- | |
| Total Liabilities | 33.12M | 25.57M | -- | -- | |
|
|
|||||
| Common Stock & APIC | 2.38M | 2.18M | -- | -- | |
| Retained Earnings | -89.78M | -83.01M | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -87.40M | -80.83M | -74.48M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 70.60M | 70.60M | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 70.60M | 70.60M | 70.60M | -- | |
|
|
|||||
| Total Common Equity | -87.40M | -80.83M | -74.48M | -- | |
| Total Preferred Equity | 70.60M | 70.60M | 70.60M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -16.80M | -10.23M | -3.88M | -- | |
|
|
|||||
